Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
Want to stay on top of the science and politics driving biotech today?
Sign up
to get our biotech newsletter in your inbox.
The Trump administration is touting massive projected savings from its still-secret drug pricing deals, though outside experts say there’s little way to independently verify the math.
Also, FDA leadership is facing fresh accusations of political interference in drug reviews, AI oncology startups are trying to make cancer care virtual, and scientists are opening up an entirely new frontier of biology hidden inside the “dark proteome.”
Continue to STAT+ to read the full story…
— Source: STAT News (https://www.statnews.com/2026/05/07/biotech-news-fda-reconsiders-rare-cancer-treatment-after-surprise-rejection/)
